Clinical Trials Browser

Risk Assessment × Gastrointestinal × 90 days × Clear all

NCT07206589 2026-04-17

Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial

Phase NA Not yet recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus